Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
about
Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention.Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer ScreeningPolicy of screening for colorectal cancer in Saudi Arabia: A prospective analysis.Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms: A retrospective studyExo70 is an independent prognostic factor in colon cancer.Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort.IL-32α-induced inflammation constitutes a link between obesity and colon cancer.Colorectal cancer screening: An updated review of the available options.Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data.Colorectal cancer screening at US community health centers: Examination of sociodemographic disparities and association with patient-provider communication.Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.Older Adults' Views and Communication Preferences About Cancer Screening Cessation.Preventive Interventions for the Second Half of Life: A Systematic Review.Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.Which Fecal Immunochemical Test Should I Choose?A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.Predictors of primary care provider adoption of CT colonography for colorectal cancer screening.Expanding the Scope of an Automated Radiology Recommendation-Tracking Engine: Initial Experiences and Lessons Learned.The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis.Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population.Colorectal Cancer Incidence Patterns in the United States, 1974-2013.Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.Surrogate end points save lives.The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from ThailandCancer Screening Reminders: Addressing the Spectrum of Patient Preferences.The toll of not screening for colorectal cancer.Methods and novel technology for microRNA quantification in colorectal cancer screening.Cost Effectiveness of Age-specific Screening Intervals for People With Family Histories of Colorectal Cancer.Evaluation of a fecal immunochemistry test prior to colonoscopy for outpatients with various indications.Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”.Colonoscopy overuse in colorectal cancer screening and associated factors in Argentina: a retrospective cohort study.Hypothesis: Induction of biomarkers for detection of colonic neoplasms.Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review.Screening for Colorectal Cancer at the Worksite.Reactions to online colorectal cancer risk estimates among a nationally representative sample of adults who have never been screened.
P2860
Q30241072-F651AD3B-47E8-49CD-9133-21CDF847717EQ30243864-54BDF5D0-65AB-47ED-8BCF-1FEC99E19F39Q33796519-155C4461-9C2A-4561-BC64-5A0C62C06ECEQ33803927-C599CEFE-1AD5-41BB-9C4E-061F86ECAABBQ33894800-ADC8E022-059C-4D0A-9D18-1B80C4E63B0FQ36409308-DDDC9781-D4DC-4AD7-A0D7-CBC098670E80Q37521975-0FB54960-99FB-4276-B729-E72831564A75Q38287509-D42777EA-F7D3-4933-8103-64325A0A428FQ38368844-4C53231C-7649-446B-A687-69C76968417AQ38370964-F40A7428-53D8-4A75-BFF5-B46A5A3B26E0Q38398887-377A951F-3BEC-422B-A901-A7EF23D1FDF3Q38657542-F6859234-A33E-46D3-B9A9-B77DC18368E4Q38668005-856E1733-D6E8-4060-AFA9-68A2B45B4E95Q38671987-E8B6CF2E-8E1C-4212-85AE-14BA114978ABQ38730815-596A227F-C698-45B2-BC11-BDEC0D92F501Q38787080-2994E335-B86C-4558-B7D0-EEC3A04E2C74Q38817436-05C5A645-B462-4B6C-92DE-F6A8D88410FCQ38995620-860012B1-A7B2-4E16-B860-6125E04F7E1CQ39120155-EF814A67-231C-443D-AA42-550B07A9704BQ39172937-541452EB-AD9A-4143-983D-F2196857F129Q39198323-46B82B29-9D23-470F-A012-304EA818576DQ39360779-63A2B3AF-3867-469A-BD93-BBC73D412514Q40056488-E0BD0DA4-4520-4AD0-9E4E-A8251674D2ACQ40091984-7E909D83-ACD8-4A94-8E01-65CB59A513D1Q40100455-04B59DAC-35D5-4400-88F4-1AE8D02457D3Q40258714-34FF36A0-A23F-4AE0-8FD5-481A3DB5CDC0Q41335590-F6AAD857-F7BD-41AD-85CE-BD927B76FFB0Q41910829-02ADFF4C-3115-44D2-87F1-0B4D47EFA0A7Q42143973-85851730-1AAF-4501-9145-A6A6BF08C672Q42375888-68B97597-1CD3-4DBF-9C1E-270F76A982E8Q43574017-2EB1C3E2-1E16-4FF6-9E07-E11F8DABC0F1Q44385577-3BDA5DC9-C2DD-431C-A04C-FFB2B3050DC8Q45068881-959B1EF0-6DC1-4BD5-9479-B6B44F03A523Q45338400-E8F29AD2-7F87-41E2-AD5D-B49EB97D84B4Q46095193-B761B814-383E-40EE-94A6-92090486599AQ47124009-B1971B40-00E7-4354-8C49-C4876EAD1C9BQ47152763-59E7C5C6-16A6-4397-BDCB-FFB88F5FD74AQ47156345-7410CF4D-98EE-4750-84BE-BEDFE149EF56Q47246395-2F9A712C-8A47-4BDA-BEB1-9D9A067E63A7Q47284914-9961A3AC-DF47-4E23-9FD1-F7600AB2A6CC
P2860
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Screening for Colorectal Cance ...... reventive Services Task Force.
@ast
Screening for Colorectal Cance ...... reventive Services Task Force.
@en
type
label
Screening for Colorectal Cance ...... reventive Services Task Force.
@ast
Screening for Colorectal Cance ...... reventive Services Task Force.
@en
prefLabel
Screening for Colorectal Cance ...... reventive Services Task Force.
@ast
Screening for Colorectal Cance ...... reventive Services Task Force.
@en
P2093
P31
P356
P1476
Screening for Colorectal Cance ...... reventive Services Task Force.
@en
P2093
Carolyn M Rutter
Elizabeth M Webber
Elizabeth O'Connor
Evelyn P Whitlock
Jennifer S Lin
Leslie A Perdue
Margaret A Piper
Ning Smith
P304
P356
10.1001/JAMA.2016.3332
P407
P577
2016-06-15T00:00:00Z